Created at 8:31 p.m. Nov, 08, 2024
Author: anknovice
Related Note: 1462849196492 1
Rationale for change

Previously stated that long acting insulin is administered twice daily.
this is only if diabetes is severely uncontrolled (A1C > 13/14). If a patient takes long acting insulin twice a day, they will likely have a hypoglycemic emergency...

It is typically only administered once daily, according to UWorld ID 850.
"Long-acting insulins (eg, glargine) mimic basal insulin secretion; they have an extended duration of action and little or no peak effect. They are typically given once daily and suppress fasting hyperglycemia, which is predominantly caused by inappropriate hepatic gluconeogenesis."

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#AMBOSS::vVaAwj #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::04_Insulin #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*Insulin_Preparations::Long_Acting #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::01_Insulin_Preparations #AK_Step1_v12::#UWorld::Step::850 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::Step::600 #AK_Step1_v12::#UWorld::Step::15876 #AK_Step1_v12::#DirtyMedicine::05_Pharmacology::15_Diabetes_Drugs_(Oral_Antihyperglycemics_&_Insulins) #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#UWorld::COMLEX::26527 #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #PANCE::ENDO::diabetes #AK_Other::Only_Step_1 #PANCE::EOR::PEDS #AK_Step2_v12::#Bootcamp::Medicine::05_Endocrinology::01_Disorders_of_Glucose_Metabolism::05_Diabetes_Pharmacotherapy #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::04_Insulin_Preparations #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#UWorld::COMLEX::23962 #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::08_Diabetes_Type_I_Management #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step2_v12::#FirstAid::03_Endocrinology::01_Disorders_of_Glucose_Metabolism::02_Diabetes_Mellitus #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::01_Insulin_Preparations